#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians need to understand that cannabis use carries a previously underappreciated stroke risk that should inform patient counseling and risk stratification, particularly for patients with existing cardiovascular risk factors. This finding should prompt providers to add cannabis use history to routine cardiovascular assessments and consider it when evaluating younger patients presenting with stroke, as the mechanism and magnitude of risk warrant further investigation.
A recent epidemiological study found that recreational drug use, including cannabis, amphetamines, and cocaine, is associated with significantly increased stroke risk in later life. The research highlights an important cardiovascular consequence of cannabis use that extends beyond acute intoxication effects, suggesting that regular recreational cannabis consumption may contribute to long-term cerebrovascular disease through mechanisms such as increased blood pressure, vasospasm, or arrhythmia. This finding is clinically relevant as cannabis legalization increases access and normalizes use, potentially expanding the population at risk for stroke-related morbidity and mortality. Clinicians should incorporate recreational drug use history, including cannabis frequency and duration, into cardiovascular risk assessment and counseling, particularly for patients with additional stroke risk factors. Patients considering cannabis use for recreational purposes should be informed of this elevated stroke risk, especially those with personal or family history of cerebrovascular disease or other cardiovascular conditions. Clinicians and patients should weigh the cardiovascular risks associated with cannabis use when discussing its potential benefits and making informed decisions about consumption.
“What this study tells us is that we need to distinguish between cannabis used medicinally under clinical supervision and recreational use patterns that correlate with stroke risk, likely because those users tend to have multiple concurrent cardiovascular risk factors and less medical oversight. When I’m evaluating a patient’s stroke risk, I’m asking about their overall drug use pattern and frequency, not just whether they’ve ever used cannabis, because the evidence suggests it’s the chronic, unmonitored recreational consumption that creates real danger.”
🧠 A recent study linking recreational drug use including cannabis to increased stroke risk adds an important dimension to cardiovascular counseling, though clinicians should recognize that this observational research cannot definitively establish causation or isolate cannabis effects from confounding factors such as concurrent tobacco use, underlying hypertension, or other substance use patterns. The stroke risk may also vary substantially depending on route of administration, frequency of use, and individual vascular vulnerability, making it difficult to apply uniform risk estimates across diverse patient populations. Nevertheless, this finding strengthens the case for detailed substance use screening during cardiovascular risk assessments, particularly in younger patients presenting with stroke or transient ischemic attack, and warrants explicit discussion of stroke risk alongside established cannabis-related harms during patient counseling about recreational use.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: